On December 16, Gelonghui reported that Yifan Pharmaceutical (002019.SZ) announced that its wholly-owned subsidiary SciGen Pte. Ltd. recently received the Chinese Patent Medicine registration approval issued by the Health Sciences Authority (HSA) of Singapore, allowing the company’s exclusive medical insurance product, the dehumidifying and anti-itch ointment, to be sold in Singapore.
The function and indications of the dehumidifying and anti-itch ointment: clears heat and removes dampness, dispels wind and alleviates itching. It is used as an adjunct treatment for acute and subacute eczema classified as damp-heat or damp-obstruction type.
